Snyder, Robert W., M.d., Ph.d., P.c.

This study tested a drug normally used for Parkinson's disease (carbidopa-levodopa) in 35 people with wet age-related macular degeneration (AMD). The goal was to see if adding this pill to standard eye injections could improve vision and reduce the number of injections needed. Th…

This study tested a drug normally used for Parkinson's disease (carbidopa-levodopa) in 20 people with wet age-related macular degeneration (AMD). The goal was to see if it is safe and can improve vision or reduce retinal swelling. Participants had not received standard anti-VEGF …

This study tested a drug called carbidopa-levodopa, normally used for Parkinson's disease, in people with wet age-related macular degeneration (AMD). It was a 9-month extension for 35 participants who had already completed an earlier study. The goal was to see if the drug could i…